Smith & Nephew touts Pico negative-pressure wound therapy in hip, knee surgeries

Smith & Nephew (NYSE:SNN) yesterday released results from a trial of its Pico negative-pressure wound therapy system used in orthopedic surgeries, touting reductions in wound exudate distributions, dressing changes and hospital stays. The 220-patient randomized, controlled trial was carried out over 12 months at the U.K.’s Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust comparing the Pico system with standard dressings on closed surgical incisions. Data from the study indicated a reduction in the probability of experiencing excessing lengths of stay with use of the Pico system when compared to standard dressing, with the average stay being between 1 and 10 days with the Pico as compared to between 2 and 61 with standard dressings. “By introducing Pico as a prophylactic measure we have been able to demonstrate predictable wound healing following total hip and knee replacement procedures. Better wound management offers significant value to our hospital both in terms of reducing associated healthcare costs and by improving each patient’s outcome and experience,” lead author Sudheer Karlakki of RJAH said in a press release. Smith & Nephew touted a 4-fold reduction in the number of patients experiencing grade 4 distribution of wind exudate within the dressinc compared to standard wound dressing for patients undergoing joint replacement. Results indicated a 6% decrease in superficial surgical site complications, as well as a signif...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Clinical Trials Wound Care Smith & Nephew Source Type: news